Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Invested Capital (2022 - 2026)

GeneDx Holdings has reported Return on Invested Capital over the past 5 years, most recently at 0.0% for Q1 2026.

  • Quarterly Return on Invested Capital changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Invested Capital was 0.0% for Q1 2026 at GeneDx Holdings, down from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q3 2025 and troughed at 0.02% in Q1 2023.
  • The 5-year median for Return on Invested Capital is 0.0% (2024), against an average of 0.01%.
  • The largest YoY upside for Return on Invested Capital was 1bps in 2023 against a maximum downside of -1bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.01% in 2022, then skyrocketed by 51bps to 0.01% in 2023, then soared by 88bps to 0.0% in 2024, then surged by 59bps to 0.0% in 2025, then plummeted by -406bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for WGS's Return on Invested Capital are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).